USANA Health Sciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$USNA
Medicinal Chemicals and Botanical Products
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________________
FORM 8-K
_____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation)
| (Commission File No.) | (IRS Employer Identification No.) | ||||
(Address of principal executive offices, Zip Code)
Registrant's telephone number, including area code: (801 ) 954-7100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company held its Annual Meeting of Shareholders on May 6, 2024. A total of 17,520,055 shares (approximately 91%) of the issued and outstanding shares of USANA common stock were represented by proxy or in person at the meeting. The following matters were submitted and voted upon at the Annual Meeting:
1.USANA shareholders voted to elect eight individuals to the Board of Directors for the succeeding year as set forth below:
| Name | Number of Shares For | Number of Shares Withheld | Number of Shares Abstaining | Broker Non-Votes | ||||||||||||||||||||||
| Kevin G. Guest | 16,858,545 | 118,418 | - | 543,092 | ||||||||||||||||||||||
| Xia Ding | 16,639,033 | 337,930 | - | 543,092 | ||||||||||||||||||||||
| John T. Fleming | 16,620,330 | 356,633 | - | 543,092 | ||||||||||||||||||||||
| Gilbert A. Fuller | 15,908,052 | 1,068,911 | - | 543,092 | ||||||||||||||||||||||
| J. Scott Nixon, CPA | 16,615,187 | 361,776 | 543,092 | |||||||||||||||||||||||
| Peggie J. Pelosi | 16,623,358 | 353,605 | - | 543,092 | ||||||||||||||||||||||
| Frederic Winssinger | 16,552,853 | 424,110 | - | 543,092 | ||||||||||||||||||||||
| Timothy E. Wood, Ph.D. | 16,618,063 | 358,900 | - | 543,092 | ||||||||||||||||||||||
2.USANA shareholders voted to ratify the Board’s selection of KPMG LLP as our independent registered public accounting firm for fiscal year 2024 as set forth below:
| Number of Shares For | Number of Shares Against | Number of Shares Abstaining | Broker Non-Votes | |||||||||||||||||
| 17,458,617 | 60,804 | 634 | - | |||||||||||||||||
3.USANA shareholders voted to approve, on an advisory basis, executive compensation as set forth below:
| Number of Shares For | Number of Shares Against | Number of Shares Abstaining | Broker Non-Votes | |||||||||||||||||
| 16,559,671 | 414,043 | 3,249 | 543,092 | |||||||||||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| USANA HEALTH SCIENCES, INC. | ||||||||
| By: | /s/ G. Douglas Hekking | |||||||
| G. Douglas Hekking, Chief Financial Officer | ||||||||
| Date: May 7, 2024 | ||||||||